AzTrials
AzTrials

No ConditionSmart NeedleNCT07302997

Real-Time Monitoring of the Injection Pressure During the Peripheral Nerve Block

A study testing Smart Needle Monitoring System in people with No Condition and Real-time Monitoring of the Injection Pressure During Ultrasound-guided Axillary Block, run by Ente Ospedaliero Cantonale, Bellinzona at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial with medical device is to learn if the Smart Needle Monitoring System works to maintain a safe low injection pressure during a type of regional anaesthetic (Peripheral Nerve Block (PNB)) in patients due to undergo surgery below the elbow . Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Smart Needle Monitoring System
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteSwitzerland
Study dates
19 Dec 2025to 14 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informed Consent signed by the subject
  • Age ≥ 18 years
  • Scheduled for elective surgery below the elbow (e.g., hand surgery, distal radius surgery, forearm surgery) requiring an axillary block
  • ASA physical status I-III
  • Ability to understand the investigation
  • Ability and willingness to follow and complete the procedures of the investigation

Who cannot join

  • Contraindications to the axillary block (e.g., local infection)
  • Refusal of locoregional anesthesia for the surgical procedure
  • Pre-existing neurologic deficits in the operative extremity
  • Body Mass Index ≥ 35 kg/m2
  • Known allergy to local anesthetic (mepicavaine hydrochloride)
  • Inability to comply with post-operative evaluations e.g. due to language problems, psychological disorders, dementia, etc. of the subject

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Ospedale Regionale di Bellinzona e Valli, EOC

    Bellinzona

Other trials in Switzerland

About this study

Official title: A Single-Center, First-in-Human, Randomized, Controlled, Feasibility Study of a New Device for the Real-Time Continuous Monitoring of the Injection Pressure of Local Anesthetic in Subjects Undergoing Ultrasound-guided Peripheral Nerve Block: the Smart Needle Monitoring System Investigation

The goal of this clinical trial with medical device is to learn if the Smart Needle Monitoring System works to maintain a safe low injection pressure during a type of regional anaesthetic (Peripheral Nerve Block (PNB)) in patients due to undergo surgery below the elbow . It will also learn about the safety of the device and patients' perception of the quality of anesthesia.

Participants will:

  • be operated locally according to standard clinical practice
  • undergo post-anesthesia recovery and any neurologic symptoms or signs assessment on postoperative days 1 and 7
Being tested
Smart Needle Monitoring System
Keywords
axillary block, injection pressure, real-time monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart Needle Monitoring SystemDevice

    The Smart Needle Monitoring System is used to perform the ultrasound-guided axillary block. The monitor connected to the Smart Needle will display real-time and record the injection pressure profile during the entire PNB procedure

Study groups in NCT07302997
Study groupRoleWhat they receive
Smart Needle displayingExperimentalThe Smart Needle Monitoring System is used to perform the ultrasound-guided axillary block. The monitor connected to the Smart Needle will display real-time and record the injection pressure profile during the entire PNB procedure. The anesthesiologist will use the real-time visual feedback to maintain a low injection pressure profile (i.e., not higher than 15 psi) and avoid pressure peaks. The anesthesiologist can immediately stop the injection if there is a sudden increase in pressure, reposition the needle and start again, while always maintaining a low injection pressure profile
Receives: Device: Smart Needle Monitoring System
Smart Needle flippedOtherThe Smart Needle Monitoring System is used to perform the ultrasound-guided axillary block. The monitor connected to the Smart Needle will be flipped allowing the recording of the injection pressure but not the real-time visualization by the anesthesiologist, who will perform the procedure as usual without a pressure visual feedback
Receives: Device: Smart Needle Monitoring System

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. proportion of injected nerves with at least one injection pressure peak in the investigational group compared to the standard (control) group

    The proportion of injected nerves with at least one injection pressure peak in the investigational group compared to the standard (control) group. A peak is defined as an injection pressure reaching a value above the threshold of 15 psi

    Measured: Perioperative

Secondary outcomes (4)
  1. Success of the block

    Success of the block is defined as no conversion to general anesthesia (avoidance of rescue block, etc.)

    Measured: Perioperative

  2. Number of times of needle tip repositioning

    Number of times of needle tip repositioning, defined as the need to stop the ultrasound- guided PNB procedure to avoid excessive high pressure and reposition the needle tip

    Measured: Perioperative

  3. Total number of injection pressure peaks

    Total number of injection pressure peaks, i.e. raises of the injection pressure above the threshold of 15 psi, for each injected nerve

    Measured: Perioperative

  4. Quality of anesthesia from a patient's perspective

    Interview to the patient with 8 questions about quality of anesthesia from a patient's perspective in terms of pain, perception of needle movements and discomfort during the anesthesia procedure, and overall satisfaction; both Closed-ended questions and questions with scores 0 (worst) to 10 (best)

    Measured: postoperative, 1 and 7 days after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start19 Dec 2025
  3. Primary completion14 Aug 2026
  4. Study completion14 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07302997
Sponsor's protocol ID
2025-D0048
Acronym
Smart Needle
Status last verified
Oct 2026
First submitted
27 Nov 2025
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Smart Needle Monitoring System in people with No Condition and Real-time Monitoring of the Injection Pressure During Ultrasound-guided Axillary Block, run by Ente Ospedaliero Cantonale, Bellinzona at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

proportion of injected nerves with at least one injection pressure peak in the investigational group compared to the standard (control) group (time frame: Perioperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in